PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, announces that the Company will be participating at Source Capital’s 2016 Disruptive Growth & Healthcare Conference taking place February 10-11, 2016 in New York City. Kenneth A. Berlin, Chief Executive Officer of Rosetta Genomics, will deliver the corporate presentation at 11:15 a.m. Eastern time on February 11th.
